Piper Sandler maintains Neutral rating on Okta stock amid growth concerns

Okta (OKTA) reported strong fiscal second-quarter results, exceeding expectations with improved execution, maintaining ~77% gross margins, and achieving ~14% LTM revenue growth, prompting management to raise FY26 revenue guidance by $25 million and improve EBIT/FCF margin outlook. While Piper Sandler reiterated a Neutral rating with a $110 price target, citing a balanced risk/reward and uncertainty for a second-half inflection, other firms including KeyBanc ($140), Stifel ($130), UBS ($130), Bernstein ($129), and Cantor Fitzgerald ($130) reiterated Buy/Overweight ratings, reflecting broad analyst optimism on Okta's performance and future prospects driven by new product launches and recent acquisitions.

Analysis

Okta, Inc. (OKTA) reported a strong fiscal second quarter, demonstrating improved execution with performance metrics exceeding guidance. The company maintains robust gross profit margins of approximately 77% and has delivered revenue growth of around 14% over the last twelve months. In response to the strong first-half performance, management raised its fiscal year 2026 revenue guidance by $25 million and improved its outlook for EBIT and free cash flow margins. This has led to a broadly optimistic view from the analyst community, with firms like KeyBanc, Stifel, UBS, and Cantor Fitzgerald reiterating Overweight or Buy ratings with price targets between $130 and $140. However, Piper Sandler offered a more cautious perspective, reiterating its Neutral rating and $110 price target. This caution is rooted in uncertainty over a second-half growth inflection and management's admission that its 10% third-quarter current remaining performance obligations (cRPO) guidance contains less conservatism than previous forecasts. The forward narrative, which underpins the bullish case, is centered on new product launches such as OIG/OPA, a recent acquisition in privileged access management (PAM), and early-stage AI developments.

Key Decisions for Investors

• Investors should weigh the strong Q2 beat and raised guidance against the divergence in analyst ratings, particularly Piper Sandler's caution regarding the conservatism of forward-looking cRPO guidance.
• Monitor the upcoming third-quarter cRPO figures closely, as they will be a key indicator of whether the growth momentum is sustainable and will validate the more optimistic analyst outlooks.
• Consider the stock's future performance to be heavily dependent on the successful launch and market adoption of its new products in identity governance and privileged access management, which are central to its long-term growth narrative.